AVEIR™ Leadless Pacemaker (LP) United Kingdom (UK) Registry
AVEIR™ Leadless Pacemaker United Kingdom Registry
Royal Brompton & Harefield NHS Foundation Trust
300 participants
Apr 15, 2025
OBSERVATIONAL
Conditions
Summary
This observational study will follow patients requiring implantation of leadless pacemaker for 5 years after implantation. The main goal is to evaluate the long term safety and efficacy of AVEIR™ leadless pacemaker device in the usual clinical settings within the UK National Health Service. In addition, the study will collect data to understand patient characteristics receiving this type of pacemaker.
Eligibility
Inclusion Criteria3
- Patient is intended to receive or was treated with a (AVEIR™) Leadless Transcatheter Pacing
- Subject is willing to comply with clinical investigation procedures and agrees to return for all required follow-up visits, tests, and exams; and
- Subject has been informed of the nature of the study, agrees to its provisions, and has provided a signed written informed consent, approved by the Regional Ethics Committee (REC).
Exclusion Criteria3
- Subject is not suitable for implantation of the leadless device according to the expert opinion of their cardiologist.
- Subject is not willing to comply with clinical investigation procedures and does not agree to return for all required follow-up visits, tests, and exams
- Subject has been informed of the nature of the study, but does not agree to its provisions, and has not provided a signed written informed consent, approved by the REC
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
AVEIR™ leadless pacemaker implantation
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06854484